Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2024-09-16 | 2024-10-15 | 237750 |
SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Resolved | 2024-10-28 | 2024-12-11 | 241400 |
SANDOZ IRBESARTAN HCT | 12.5MG 300MG | TABLET | Actual shortage | 2025-01-27 | 2025-03-10 | 248642 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2017-03-14 | 2017-05-08 | 2705 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2017-03-15 | 2017-05-08 | 2887 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2017-09-07 | 2017-10-25 | 21284 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2019-04-01 | 2020-07-20 | 80197 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2019-04-01 | 2020-07-20 | 80200 |
SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124617 |
SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124621 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 |